A Clinical Trial of Oral Versus IV Iron in Patients With Chronic Kidney Disease
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The long-term goal is to assess the fall in kidney function measured by glomerular filtration
rate (GFR) when patients with chronic kidney disease (CKD) are exposed to intravenous iron
(IVIR). We hypothesize that in subjects with mild to moderate CKD, infusion of intravenous
iron (IVIR), will generate oxidative stress and cause an inflammatory response that will be
associated with a more rapid decline in glomerular filtration rate (GFR) compared to oral
iron.
Phase:
Phase 4
Details
Lead Sponsor:
Indiana University
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)